TL;DR: In the recent outbreak of novel coronavirus infection in Wuhan, China, significantly abnormal coagulation parameters in severe novel coronvirus pneumonia (NCP) cases were a concern.
TL;DR: Deep-vein thrombosis can be ruled out in a patient who is judged clinically unlikely to have deep-veIn thromBosis and who has a negative D-dimer test, and ultrasound testing can be safely omitted in such patients.
Abstract: background Several diagnostic strategies using ultrasound imaging, measurement of d -dimer, and assessment of clinical probability of disease have proved safe in patients with suspected deep-vein thrombosis, but they have not been compared in randomized trials. methods Outpatients presenting with suspected lower-extremity deep-vein thrombosis were potentially eligible. Using a clinical model, physicians evaluated the patients and categorized them as likely or unlikely to have deep-vein thrombosis. The patients were then randomly assigned to undergo ultrasound imaging alone (control group) or to undergo d -dimer testing ( d -dimer group) followed by ultrasound imaging unless the d -dimer test was negative and the patient was considered clinically unlikely to have deep-vein thrombosis, in which case ultrasound imaging was not performed. results Five hundred thirty patients were randomly assigned to the control group, and 566 to the d -dimer group. The overall prevalence of deep-vein thrombosis or pulmonary embolism was 15.7 percent. Among patients for whom deep-vein thrombosis had been ruled out by the initial diagnostic strategy, there were two confirmed venous thromboembolic events in the d -dimer group (0.4 percent; 95 percent confidence interval, 0.05 to 1.5 percent) and six events in the control group (1.4 percent; 95 percent confidence interval, 0.5 to 2.9 percent; P=0.16) during three months of follow-up. The use of d -dimer testing resulted in a significant reduction in the use of ultrasonography, from a mean of 1.34 tests per patient in the control group to 0.78 in the d -dimer group (P=0.008). Two hundred eighteen patients (39 percent) in the d- dimer group did not require ultrasound imaging. conclusions Deep-vein thrombosis can be ruled out in a patient who is judged clinically unlikely to have deep-vein thrombosis and who has a negative d -dimer test. Ultrasound testing can be safely omitted in such patients.
TL;DR: Few observations exist with respect to the pro‐coagulant profile of patients with COVID‐19 acute respiratory distress syndrome and reports of thromboembolic complications are scarce but suggestive for a clinical relevance of the problem.
TL;DR: The D-dimer antigen is a unique marker of fibrin degradation that is formed by the sequential action of 3 enzymes: thrombin, factor XIIIa, and plasmin, and an overview of commercially available D- dimer assays is provided.
TL;DR: A systematic review of the literature to assess the sensitivity and specificity of the d-dimer assays and the variability of those measures among studies for diagnosing DVT and PE found none of the assays had positive likelihood values that greatly increased the certainty of diagnosis.
Abstract: Excluding a diagnosis from consideration requires a test result that will reduce its probability to below a threshold. Among tests for D-dimer, enzyme-linked immunosorbent assays (ELISAs) had the h...